BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 27084107)

  • 21. Simvastatin-doped pre-mixed calcium phosphate cement inhibits osteoclast differentiation and resorption.
    Montazerolghaem M; Rasmusson A; Melhus H; Engqvist H; Karlsson Ott M
    J Mater Sci Mater Med; 2016 May; 27(5):83. PubMed ID: 26968758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive modulation of osteogenesis- and osteoclastogenesis-related gene expression with strontium-containing microstructured Ti implants in rabbit cancellous bone.
    Park JW; Kim YJ; Jang JH; Song H
    J Biomed Mater Res A; 2013 Jan; 101(1):298-306. PubMed ID: 23065737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gelatin-Modified Calcium/Strontium Hydrogen Phosphates Stimulate Bone Regeneration in Osteoblast/Osteoclast Co-Culture and in Osteoporotic Rat Femur Defects-In Vitro to In Vivo Translation.
    Kruppke B; Ray S; Alt V; Rohnke M; Kern C; Kampschulte M; Heinemann C; Budak M; Adam J; Döhner N; Franz-Forsthoffer L; El Khassawna T; Heiss C; Hanke T; Thormann U
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33153127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced ectopic bone formation by strontium-substituted calcium phosphate ceramics through regulation of osteoclastogenesis and osteoblastogenesis.
    Chen F; Tian L; Pu X; Zeng Q; Xiao Y; Chen X; Zhang X
    Biomater Sci; 2022 Oct; 10(20):5925-5937. PubMed ID: 36043373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and properties of novel gallium-doped injectable apatitic cements.
    Mellier C; Fayon F; Boukhechba F; Verron E; LeFerrec M; Montavon G; Lesoeur J; Schnitzler V; Massiot D; Janvier P; Gauthier O; Bouler JM; Bujoli B
    Acta Biomater; 2015 Sep; 24():322-32. PubMed ID: 26074157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium Phosphate Silicate and Calcium Silicate Cements Suppressing Osteoclasts Activity Through Cytokine Regulation.
    Yuan W; He X; Zhang J; Chen Y; Gong T; Zhu Y
    J Nanosci Nanotechnol; 2018 Oct; 18(10):6799-6804. PubMed ID: 29954496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteoclastogenic capacity of peripheral blood mononuclear cells is not different between women with and without osteoporosis.
    Koek WNH; van der Eerden BCJ; Alves RDAM; van Driel M; Schreuders-Koedam M; Zillikens MC; van Leeuwen JPTM
    Bone; 2017 Feb; 95():108-114. PubMed ID: 27845263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effect of Zn2+ in zinc-containing beta-tricalcium phosphate on resorbing activity of mature osteoclasts.
    Yamada Y; Ito A; Kojima H; Sakane M; Miyakawa S; Uemura T; LeGeros RZ
    J Biomed Mater Res A; 2008 Feb; 84(2):344-52. PubMed ID: 17618520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of gastrointestinal proton pump inhibitors to regulate osteoclast-mediated resorption of calcium phosphate cements in vivo.
    Sheraly AR; Lickorish D; Sarraf F; Davies JE
    Curr Drug Deliv; 2009 Apr; 6(2):192-8. PubMed ID: 19450226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble silica inhibits osteoclast formation and bone resorption in vitro.
    Mladenović Ž; Johansson A; Willman B; Shahabi K; Björn E; Ransjö M
    Acta Biomater; 2014 Jan; 10(1):406-18. PubMed ID: 24016843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased levels of sodium chloride directly increase osteoclastic differentiation and resorption in mice and men.
    Wu L; Luthringer BJC; Feyerabend F; Zhang Z; Machens HG; Maeda M; Taipaleenmäki H; Hesse E; Willumeit-Römer R; Schilling AF
    Osteoporos Int; 2017 Nov; 28(11):3215-3228. PubMed ID: 28849275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strontium enhances osseointegration of calcium phosphate cement: a histomorphometric pilot study in ovariectomized rats.
    Baier M; Staudt P; Klein R; Sommer U; Wenz R; Grafe I; Meeder PJ; Nawroth PP; Kasperk C
    J Orthop Surg Res; 2013 Jun; 8():16. PubMed ID: 23758869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro.
    Bonnelye E; Chabadel A; Saltel F; Jurdic P
    Bone; 2008 Jan; 42(1):129-38. PubMed ID: 17945546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary evaluation of different biomaterials for defect healing in an experimental osteoporotic rat model with dynamic PET-CT (dPET-CT) using F-18-sodium fluoride (NaF).
    Cheng C; Alt V; Pan L; Thormann U; Schnettler R; Strauss LG; Schumacher M; Gelinsky M; Dimitrakopoulou-Strauss A
    Injury; 2014 Mar; 45(3):501-5. PubMed ID: 24332163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of osteoclast activities by SCPC bioceramic promotes osteoblast-mediated graft resorption and osteogenic differentiation.
    El-Ghannam A; Nakamura M; Muguruza LB; Sarwar U; Hassan M; Fotawi RA; Horowitz R
    J Biomed Mater Res A; 2021 Sep; 109(9):1714-1725. PubMed ID: 33733590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strontium exerts dual effects on calcium phosphate cement: Accelerating the degradation and enhancing the osteoconductivity both in vitro and in vivo.
    Kuang GM; Yau WP; Wu J; Yeung KW; Pan H; Lam WM; Lu WW; Chiu KY
    J Biomed Mater Res A; 2015 May; 103(5):1613-21. PubMed ID: 25087971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relevance of osteoclast-specific enzyme activities in cell-based in vitro resorption assays.
    Bernhardt A; Koperski K; Schumacher M; Gelinsky M
    Eur Cell Mater; 2017 Jan; 33():28-42. PubMed ID: 28098926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mg:Ca ratio as regulating factor for osteoclastic in vitro resorption of struvite biocements.
    Blum C; Brückner T; Ewald A; Ignatius A; Gbureck U
    Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():111-119. PubMed ID: 28183587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.